InvestorsHub Logo
Followers 7
Posts 1284
Boards Moderated 0
Alias Born 11/05/2011

Re: Babubd post# 1637

Wednesday, 08/12/2020 3:59:27 PM

Wednesday, August 12, 2020 3:59:27 PM

Post# of 1738
Incremental moves to $10. Waiting patiently until fourth quarter sales come in! With the recent drastic move over $5 and touching $6 briefly over the last few days I feel something big is coming!

“The recent FDA approval of Gimoti, the first and only outpatient treatment option that bypasses the stomach to relieve symptoms in adults with acute and recurrent diabetic gastroparesis, marked the most significant milestone in our history,” said David A. Gonyer, R.Ph., President and CEO of Evoke Pharma. “We are currently focused on the commercial launch of Gimoti during the fourth quarter of 2020 with EVERSANA, our commercial partner. EVERSANA is working with us to fully implement our strategy, while leveraging their integrated suite of commercialization capabilities. Simultaneously, we have manufactured the first commercial batch of Gimoti with our contract manufacturing partner, Patheon. We believe that we will be well prepared to launch Gimoti and look forward to providing patients with diabetic gastroparesis the only outpatient non-oral treatment option to help improve gastroparesis patients’ quality of life.”

$EVOK

Just my honest opinion
S777

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVOK News